# Effect of Bydureon on Carotid Atherosclerosis Progression in Type 2 Diabetes Mellitus

Study · id `cardio:ct-nct02162550` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02162550](<https://clinicaltrials.gov/study/NCT02162550>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02162550

Browse, organ or system: Blood vessels; Metabolism  
Browse, condition area: Coronary and vascular disease; Diabetes and metabolic disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 148 participants.

## Technical summary

Registry record NCT02162550. Randomized; quadruple masking; primary purpose treatment. Start 2014-06 (registry gives no type); primary completion 2019-04 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 148 participants (planned count; ClinicalTrials.gov record NCT02162550, source copy `cardio:ctgov-nct02162550-2018-06-14`, retrieved 2026-10-26)
- Start date: 2014-06 (registry gives no type) (ClinicalTrials.gov record NCT02162550, source copy `cardio:ctgov-nct02162550-2018-06-14`, retrieved 2026-10-26)
- Primary completion: 2019-04 (anticipated) (ClinicalTrials.gov record NCT02162550, source copy `cardio:ctgov-nct02162550-2018-06-14`, retrieved 2026-10-26)
- Completion: 2019-09 (anticipated) (ClinicalTrials.gov record NCT02162550, source copy `cardio:ctgov-nct02162550-2018-06-14`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT02162550, source copy `cardio:ctgov-nct02162550-2018-06-14`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02162550-2018-06-14`, retrieved 2026-10-26)

## The registry's words

- Brief title: Effect of Bydureon on Carotid Atherosclerosis Progression in Type 2 Diabetes Mellitus
- Condition: Type 2 Diabetes
- Intervention (Drug): Bydureon
- Intervention (Drug): placebo
- Lead sponsor: Phoenix VA Health Care System
- Lead sponsor class: FED

## Connected pages

- Registry condition terms include this condition: Atherosclerosis (`cardio:atherosclerosis`)
- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry condition terms include this condition: Diabetes mellitus (`core:diabetes-mellitus`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: The Effect of Exenatide Once Weekly on Carotid Atherosclerosis in Individuals With Type 2 Diabetes: An 18-Month Randomized Placebo-Controlled Study (`cardio:pubmed-33495294`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 76c86a40aa7f65e8787f099fda285b10a7dc364b4b817acf4d63c2337229c59c
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
